Article Details

Syndax Pharmaceuticals (SNDX) Earns Buy Rating from Analysts at HC Wainwright

Retrieved on: 2018-07-14 20:56:15

Tags for this article:

Click the tags to see associated articles and topics

Syndax Pharmaceuticals (SNDX) Earns Buy Rating from Analysts at HC Wainwright. View article details on hiswai:

Excerpt

<div><b>Sofinnova Ventures</b> Inc acquired a new stake in shares of Syndax Pharmaceuticals in the first quarter valued at about $173,000. Finally, Renaissance ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up